Clear Harbor Asset Management’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Clear Harbor Asset Management’s Portfolio NBRV Stock Details NBRV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-8	Closed	-$1.07K	–	813
2020 Q3	$1.07K	Buy	+8	New	+$1.34K	﹤0.01%	762
2020 Q1	–	Sell	-8	Closed	-$2.64K	–	778
2019 Q4	$2.64K	Buy	+8	New	+$3.67K	﹤0.01%	720
2019 Q2	–	Sell	-142	Closed	-$87K	–	271
2019 Q1	$87K	Sell	142 -258	-65%	-$141K	0.02%	235
2018 Q4	$146K	Sell	400 -450	-53%	-$242K	0.03%	214
2018 Q3	$443K	Buy	850 +784	+1,188%	+$556K	0.09%	151
2018 Q2	$57K	Buy	66 +18	+38%	+$20.6K	0.01%	248
2018 Q1	$60K	Sell	48 -13	-21%	-$19.2K	0.01%	227
2017 Q4	$92K	Buy	+61	New	+$96.5K	0.02%	234

Other funds holding NBRV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

AICPI

ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Clear Harbor Asset Management's NBRV Position: Q4 2020 in Review

Clear Harbor Asset Management sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q4 2020, closing a stake of 8 shares — an estimated $1.07K sold.

Clear Harbor Asset Management first reported a position in NBRV in Q4 2017 and held it in 8 quarters. The position peaked at $443K in Q3 2018. 33 funds tracked by Wall St. Rank hold NBRV as of Q4 2020.

Clear Harbor Asset Management reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q4 2020 after selling out during the quarter.
Clear Harbor Asset Management sold 8 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q4 2020, an estimated $1.07K.
Clear Harbor Asset Management first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q4 2017 and held it in 8 quarters.
Clear Harbor Asset Management's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $443K in Q3 2018.
33 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q4 2020.

Based on Clear Harbor Asset Management's 13F filing for Q4 2020, filed 4 Feb 2021.